LUCY Innovative Eyewear, Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.76
P/S
1.37
EV/EBITDA
0.03
DCF Value
$-21.04
FCF Yield
-187.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.5%
Operating Margin
-300.7%
Net Margin
-272.5%
ROE
-83.4%
ROA
-85.7%
ROIC
-106.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $773.6K | $-2.3M | $— |
| Q4 null | $959.8K | $-1.9M | $— |
| FY null | $2.7M | $-7.6M | $— |
| Q3 null | $668.1K | $-1.8M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
2.69
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.